Matthew C. Cave

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes

Swati Joshi‐Barve, Shirish Barve, Kiranmayi Amancherla et al. · Hepatology · 2007 · 402 citations · Full text

The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction

Wei Zhong, Craig J. McClain, Matthew C. Cave et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2010 · 210 citations · Full text

Inflammation, Nutrition, Hepatology +15

Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines

John Bassler, Alan Ducatman, Meenal Elliott et al. · Environmental Pollution · 2019 · 196 citations

Lipid Peroxidation, Pathology, Cell Death +17

Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease

Banrida Wahlang, Ming Song, Juliane I. Beier et al. · Toxicology and Applied Pharmacology · 2014 · 113 citations · Full text

Obesity, Metabolic Syndrome, Aroclor 1260 +15